Regenxbio and Nippon Shinyaku forge $810m gene therapy deal
Regenxbio will receive $110m upfront from Nippon Shinyaku and is eligible to get up to $700m in development, regulatory, and ...
ESPN21d
North Central defeats Mount Union, wins D-III championship
HOUSTON -- Luke Lehnen accounted for five touchdowns Sunday night and North Central beat Mount Union 41-25 to win its third Division III national championship. The Cardinals (15-0) appeared in ...
Boston.com22d
Joe Milton III admitted to learning he would play vs. Bills ‘after the kickoff’ in Patriots’ win
Though it may not have been a win Patriots fans wanted — with the No. 1 pick in the 2025 NFL draft hanging in the balance — rookie quarterback Joe Milton III provided a breath of fresh air on ...
Hindustan Times22d
Elon Musk makes 23 posts urging King Charles III to overthrow UK government
Elon Musk has become a political lightning rod in the United Kingdom after he advocated for King Charles III to shutdown Parliament and call for a new election. lon Musk's support for dissolving ...
Novartis28d
Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA
The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal onasemnogene abeparvovec (OAV101 IT) OAV101 IT ...